Literature DB >> 34174627

Micropollutant abatement and byproduct formation during the co-exposure of chlorine dioxide (ClO2) and UVC radiation.

Qingqing Kong1, Mengge Fan1, Ran Yin2, Xinran Zhang1, Yu Lei1, Chii Shang3, Xin Yang4.   

Abstract

Photolysis of ClO2 by UVC radiation occurs in several drinking water treatment scenarios (e.g., pre-oxidation by ClO2 with post-UVC disinfection or a multi-barrier disinfection system comprising ClO2 and UVC disinfection in sequence). However, whether micropollutants are degraded and undesired byproducts are formed during the co-exposure of ClO2 and UVC radiation remain unclear. This study demonstrated that four micropollutants (trimethoprim, iopromide, caffeine, and ciprofloxacin) were degraded by 14.4-100.0% during the co-exposure of ClO2 and UVC radiation in the synthetic drinking water under the environmentally relevant conditions (UV dose of 207 mJ cm-2, ClO2 dose of 1.35 mg L-1, and pH of 7.0). Trimethoprim and iopromide were predominantly degraded by ClO2 oxidation and direct UVC photolysis, respectively. Caffeine and ciprofloxacin were predominantly degraded by the radicals (HO• and Cl•) and the in-situ formed free chlorine from ClO2 photolysis, respectively. The yields of total organic chlorine (12.5 µg L-1 from 1.0 mg C L-1 of NOM) and chlorate (0.14 mg L-1 From 1.35 mg L-1 of ClO2) during the co-exposure were low. However, the yield of chlorite was high (0.76 mg L-1 from 1.35 mg L-1 of ClO2), which requires attention and control.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Advanced oxidation process (AOP); Chlorine dioxide (ClO(2)); Disinfection byproducts (DBPs); Micropollutants; Ultraviolet (UV)

Year:  2021        PMID: 34174627     DOI: 10.1016/j.jhazmat.2021.126424

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Radiation Exposure of Crystalline Bodies during Interventional Therapy and Related Research Status.

Authors:  Yahong Chen; Dong Zhao; Hongwei Zhong; Yiheng Zhang; Donghong An
Journal:  Contrast Media Mol Imaging       Date:  2022-07-31       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.